Curr Opin Biotechnol. 2023 Jan 7;79:102884. doi: 10.1016/j.copbio.2022.102884. Online ahead of print.
ABSTRACT
Statistical methods, especially machine learning, learning(ML), are pivotal for the analyses of large data generated by multiomics human gut microbiota study. These analyses lead to the discovery of microbe-disease associations. Furthermore, recent efforts for more data transparency and accessible analytical tools improved data availability and study reproducibility. Our recent accumulated knowledge on microbe-disease associations brings light to the next questions: what is the role of microbes in disease progression and how can we apply our knowledge of microbiome in clinical settings? Here, we introduce recent studies that implemented ML to answer the questions of causal inference and clinical translation.
PMID:36623442 | DOI:10.1016/j.copbio.2022.102884
